一项在中国健康志愿者中评价注射用福沙吡坦二甲葡胺单次给药的单中心、开放的药代动力学研究
[Translation] A single-center, open-label pharmacokinetic study evaluating single-dose fosaprepitant dimeglumine for injection in healthy Chinese volunteers
评价中国健康受试者单次静脉滴注注射用福沙吡坦二甲葡胺150 mg(以福沙吡坦计)后,福沙吡坦及其活性代谢物阿瑞匹坦的药代动力学特征及健康受试者用药后的安全性
[Translation] To evaluate the pharmacokinetics of fosaprepitant and its active metabolite aprepitant after a single intravenous infusion of fosaprepitant dimeglumine 150 mg (calculated as fosaprepitant) in healthy Chinese subjects Clinical characteristics and safety of medication in healthy subjects
一项评价注射用福沙吡坦二甲葡胺在预防高致吐性化疗所致的恶心、呕吐中的有效性及安全性研究
[Translation] A study to evaluate the efficacy and safety of fosaprepitant dimeglumine for injection in the prevention of nausea and vomiting induced by highly emetogenic chemotherapy
评估注射用福沙吡坦二甲葡胺与阿瑞匹坦胶囊对照预防高致吐性化疗所致呕吐的总体有效性和安全性
[Translation] To evaluate the overall efficacy and safety of fosaprepitant dimeglumine for injection versus aprepitant capsules in the prevention of highly emetogenic chemotherapy-induced vomiting
100 Clinical Results associated with Nanjing Westcom Biotechnology Co Ltd
0 Patents (Medical) associated with Nanjing Westcom Biotechnology Co Ltd
100 Deals associated with Nanjing Westcom Biotechnology Co Ltd
100 Translational Medicine associated with Nanjing Westcom Biotechnology Co Ltd